PureTech Health PLC Transaction in Own Shares (5312X)
21 12월 2023 - 4:00PM
UK Regulatory
TIDMPRTC
RNS Number : 5312X
PureTech Health PLC
21 December 2023
21 December 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has
purchased the following number of its ordinary shares of one pence
each through Jefferies International Limited ("Jefferies"), as part
of its Share Buyback Programme, details of which were announced on
9 May 2022.
Date of purchase: 20 December 2023
Number of ordinary shares purchased: 31,948
Highest price paid per share: 154.80p
Lowest price paid per share: 152.00p
Volume weighted average price paid per
share: 154.25p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have
17,517,641 ordinary shares in treasury and has 271,950,518 ordinary
shares in issue (excluding treasury shares). The total number of
voting rights in the Company is therefore 271,950,518 wh ich may be
used by shareholders in their calculations to determine if they are
required to notify their interest in, or a change to their interest
in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No
596/2014 (as incorporated into UK domestic law by the European
Union (Withdrawal) Act 2018) (the Market Abuse Regulation),
detailed information about the individual purchases is available
below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated
to giving life to new classes of medicine to change the lives of
patients with devastating diseases. The Company has created a broad
and deep pipeline through its experienced research and development
team and its extensive network of scientists, clinicians and
industry leaders that is being advanced both internally and through
its Founded Entities. PureTech's R&D engine has resulted in the
development of 27 therapeutics and therapeutic candidates,
including two (Plenity(R) and EndeavorRx(R)) that have received
both U.S. FDA clearance and European marketing authorization and a
third (KarXT) that has been filed for FDA approval. A number of
these programs are being advanced by PureTech or its Founded
Entities in various indications and stages of clinical development,
including registration enabling studies. All of the underlying
programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and
then advanced by the PureTech team through key validation
points.
For more information, visit www.puretechhealth.com or connect
with us on X, formerly known as Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Transaction Volume Price Platform Transaction Reference
Date Time (GBp) Number
20/12/2023 08:01:52 583 154.6 CHIX 00383161287TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 08:01:52 583 154.4 BATE 00383161288TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 08:01:52 583 154.6 XLON 00383161289TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 08:01:52 193 154.6 TRQX 00383161290TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 08:01:56 356 154.4 AQXE 00383161302TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 09:00:18 583 154.8 CHIX 00383171418TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 09:00:18 583 154.8 XLON 00383171419TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 09:02:41 583 153.6 XLON 00383171777TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 356 154.2 AQXE 00383188137TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 583 154 BATE 00383188139TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 583 154.2 CHIX 00383188138TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 415 154.2 XLON 00383188140TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 1334 154.2 XLON 00383188141TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 45 153.8 TRQX 00383188142TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 148 153.8 TRQX 00383188143TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 2 153.8 TRQX 00383188144TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 8 153.8 TRQX 00383188145TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:43:29 6 153.8 TRQX 00383188146TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 10:56:34 338 154 CHIX 00383190461TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:11:09 471 154.2 CHIX 00383192812TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:23:19 112 154.2 CHIX 00383194421TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:25:29 19 153.8 BATE 00383194647TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:27:50 363 153.8 BATE 00383194887TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:28:30 201 153.8 BATE 00383194956TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:28:30 583 153.8 CHIX 00383194957TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:29:55 823 153.4 XLON 00383195253TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:29:55 343 153.4 XLON 00383195254TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:52:12 533 152.2 CHIX 00383198720TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:52:12 1749 152.2 XLON 00383198721TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:52:12 433 152 XLON 00383198722TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 11:52:13 13 152 XLON 00383198723TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 12:37:56 16 153 XLON 00383205119TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 12:39:35 1200 153.8 XLON 00383205315TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 12:39:35 549 153.8 XLON 00383205316TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 13:01:54 3036 154.4 XLON 00383209664TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 13:01:55 105 154.4 CHIX 00383209672TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 13:01:55 773 154.4 CHIX 00383209673TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 356 154.8 AQXE 00383243718TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 583 154.8 CHIX 00383243720TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 583 154.8 BATE 00383243719TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 177 154.8 TRQX 00383243721TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 237 154.8 XLON 00383243722TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 144 154.8 XLON 00383243723TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 184 154.8 XLON 00383243725TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 18 154.8 XLON 00383243724TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 583 154.8 XLON 00383243726TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 583 154.8 XLON 00383243727TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 583 154.8 XLON 00383243728TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 583 154.8 XLON 00383243729TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 539 154.8 XLON 00383243730TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 607 154.8 XLON 00383243731TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 14:40:57 20 154.8 XLON 00383243732TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 356 154.8 AQXE 00383277253TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 583 154.8 BATE 00383277254TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 1166 154.8 CHIX 00383277256TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 193 154.8 TRQX 00383277258TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 596 154.8 XLON 00383277259TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 729 154.8 XLON 00383277260TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 2756 154.8 XLON 00383277261TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:49:32 583 154.8 XLON 00383277262TRLO0.1.1
------------ ------- ------- --------- ----------------------
20/12/2023 15:57:29 19 154.4 AQXE 00383281074TRLO0.1.1
------------ ------- ------- --------- ----------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSFLFLTFVLIFIV
(END) Dow Jones Newswires
December 21, 2023 02:00 ET (07:00 GMT)
Puretech Health (LSE:PRTC)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Puretech Health (LSE:PRTC)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
